'Mass Effect 3' has some serious requirements in order for you to get the widely accepted "good" ending, so here is a detailed guide to achieving just that.
Automated and Closed Cell Therapy Processing Systems Markets, 2030 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ARLINGTON, Va., Feb. 18, 2021 /PRNewswire/ The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, is pleased to announce the release of its 2021 technical guide:
Transit Testing Guidance for Single-Use Components and Assemblies.
The safety and performance of single-use bioprocess polymeric equipment, employed to manufacture biologic therapies and vaccines, is based on sterility and integrity and other stringent validation controls.
Delivery of single-use (SU) products requires that equipment be handled both mechanically and manually throughout the entire supply chain, from the point of manufacture to the point of use. In this vein, understanding supply chain hazards related to human error, shock, vibration, heat, compression and atmosphere will help determine the need and approach for in-depth, risk-based transit testing.
., Dec. 17, 2020 /PRNewswire/
The Bio-Process Systems Alliance (BPSA), the international industry association of the single-use bio-processing industry, is pleased to announce it expanded its Board of Directors to 19 members to lead the organization in 2021/2022 during its recent election. These Board Members will serve staggered two-year terms. Our newly expanded Board is an excellent cross-section of our membership, said BPSA Chairman Jeff Carter of Cytiva, now entering his second term. I thank them for their desire to volunteer to serve BPSA, and I truly look forward to working with them to continue to focus on the essential and safe utilization of single-use manufacturing equipment in vaccine, biopharmaceutical and cell and gene therapy production.